Acoustic droplet vapourisation (ADV) and phase‐change contrast agents (PCCAs) represent a promising frontier in biomedical ultrasound technology. By employing focused ultrasound, liquid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback